Literature DB >> 6665738

Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation.

R E Morrissey, N K Mottet.   

Abstract

Early tissue damage following a teratogenic dose of arsenic to the dam was studied in mice with the objective of detecting the primary lesion associated with the development of exencephaly. Animals were killed 6 to 21 h after a single 45 mg/kg intraperitoneal injection of sodium arsenate on day 8 of pregnancy and neurulation-stage embryos were fixed for histological and ultrastructural examination. In the prospective hindbrain, the most consistent feature associated with arsenate treatment was the widely separated neural folds which were not positioned for closure. Intracytoplasmic inclusions, interpreted as necrotic debris, were most numerous in the apical portion of the neural folds, sometimes extending into the mesenchyme, but they were not extensive in most embryos. In the prospective forebrain, necrotic debris was found throughout the neuroepithelium, in contrast to the posterior portions of the developing brain. It is not clear that necrosis of the neuroepithelium or mesenchyme would in itself be the primary lesion associated with exencephaly, although death of specific cells such as those participating in the fusion process could be involved. The potential effect of arsenate on physiological and biochemical processes which could affect neural tube closure is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6665738     DOI: 10.1002/tera.1420280311

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  11 in total

1.  Effects of meso-2,3-dimercaptosuccinic acid (DMSA) on the teratogenicity of sodium arsenate in mice.

Authors:  M A Bosque; J L Domingo; J M Llobet; J Corbella
Journal:  Bull Environ Contam Toxicol       Date:  1991-11       Impact factor: 2.151

2.  Cytoarchitectonic investigation of the rat spinal cord following ethylnitrosourea administration at different developmental stages.

Authors:  K Oyanagi; Y Yoshida; F Ikuta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

3.  Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells.

Authors:  Kumar Felix; Sunil K Manna; Kimberly Wise; Johnny Barr; Govindarajan T Ramesh
Journal:  J Biochem Mol Toxicol       Date:  2005       Impact factor: 3.642

4.  Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase.

Authors:  U Namgung; Z Xia
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

5.  Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model.

Authors:  Denise S Hill; Bogdan J Wlodarczyk; Laura E Mitchell; Richard H Finnell
Journal:  Toxicol Appl Pharmacol       Date:  2009-05-14       Impact factor: 4.219

6.  Cord blood DNA methylation of DNMT3A mediates the association between in utero arsenic exposure and birth outcomes: Results from a prospective birth cohort in Bangladesh.

Authors:  Anne K Bozack; Andres Cardenas; John Geldhof; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mostofa; David C Christiani; Molly L Kile
Journal:  Environ Res       Date:  2020-01-13       Impact factor: 6.498

7.  5-Azacytidine-induced exencephaly in mice.

Authors:  I K Takeuchi; Y K Takeuchi
Journal:  J Anat       Date:  1985-05       Impact factor: 2.610

8.  Developmental analysis of cephalic axial dysraphic disorders in arsenic-treated hamster embryos.

Authors:  S J Carpenter
Journal:  Anat Embryol (Berl)       Date:  1987

9.  Ultrastructural defects in the apical neural folds in mutant embryos with spina bifida.

Authors:  D B Wilson; D P Wyatt
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Maternal arsenic exposure and nonsyndromic orofacial clefts.

Authors:  Jonathan Suhl; Stephanie Leonard; Peter Weyer; Anthony Rhoads; Anna Maria Siega-Riz; T Renée Anthony; Trudy L Burns; Kristin M Conway; Peter H Langlois; Paul A Romitti
Journal:  Birth Defects Res       Date:  2018-10-27       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.